Lynne Braun
Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiovascular Diseases | 34 | 2021 | 410 | 5.240 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 12 | 2021 | 81 | 2.700 |
Why?
| Life Style | 15 | 2020 | 219 | 2.430 |
Why?
| Exercise | 20 | 2021 | 454 | 2.320 |
Why?
| Health Promotion | 11 | 2021 | 186 | 1.810 |
Why?
| Cholesterol | 6 | 2021 | 68 | 1.500 |
Why?
| Hypercholesterolemia | 7 | 2021 | 39 | 1.290 |
Why?
| African Americans | 8 | 2021 | 818 | 1.270 |
Why?
| Coronary Disease | 6 | 2010 | 98 | 1.150 |
Why?
| Anticholesteremic Agents | 8 | 2021 | 29 | 1.140 |
Why?
| Primary Prevention | 6 | 2021 | 53 | 1.050 |
Why?
| Risk Factors | 20 | 2020 | 2664 | 1.050 |
Why?
| Cardiology | 7 | 2018 | 102 | 0.930 |
Why?
| Risk Reduction Behavior | 8 | 2018 | 59 | 0.910 |
Why?
| Health Behavior | 6 | 2021 | 177 | 0.900 |
Why?
| Humans | 75 | 2021 | 31481 | 0.840 |
Why?
| Guidelines as Topic | 2 | 2019 | 79 | 0.790 |
Why?
| Risk Assessment | 14 | 2021 | 806 | 0.770 |
Why?
| Hyperlipidemias | 5 | 2018 | 29 | 0.760 |
Why?
| Hypertension | 9 | 2016 | 283 | 0.750 |
Why?
| Practice Guidelines as Topic | 9 | 2019 | 389 | 0.690 |
Why?
| Dyslipidemias | 5 | 2021 | 26 | 0.670 |
Why?
| Societies, Medical | 1 | 2019 | 209 | 0.650 |
Why?
| United States | 19 | 2021 | 2539 | 0.640 |
Why?
| Myocardial Infarction | 1 | 2018 | 187 | 0.620 |
Why?
| Patient Selection | 4 | 2018 | 264 | 0.600 |
Why?
| Medication Adherence | 2 | 2015 | 93 | 0.580 |
Why?
| Benchmarking | 4 | 2011 | 34 | 0.570 |
Why?
| Patient Participation | 1 | 2015 | 52 | 0.570 |
Why?
| Global Health | 3 | 2011 | 60 | 0.560 |
Why?
| Patient Compliance | 4 | 2016 | 200 | 0.560 |
Why?
| Social Environment | 1 | 2015 | 93 | 0.550 |
Why?
| Cholesterol, LDL | 6 | 2021 | 46 | 0.540 |
Why?
| Diet, Fat-Restricted | 2 | 2012 | 9 | 0.530 |
Why?
| Aged | 28 | 2020 | 10295 | 0.520 |
Why?
| Evidence-Based Medicine | 6 | 2018 | 239 | 0.520 |
Why?
| Middle Aged | 31 | 2021 | 11209 | 0.520 |
Why?
| Adult | 29 | 2019 | 9779 | 0.500 |
Why?
| Coronary Artery Disease | 4 | 2021 | 159 | 0.490 |
Why?
| Female | 35 | 2021 | 18253 | 0.480 |
Why?
| Motor Activity | 7 | 2014 | 397 | 0.460 |
Why?
| Secondary Prevention | 3 | 2021 | 67 | 0.440 |
Why?
| Health Education | 1 | 2011 | 50 | 0.420 |
Why?
| Motivation | 3 | 2021 | 102 | 0.400 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2010 | 2 | 0.400 |
Why?
| Nurses | 3 | 2021 | 51 | 0.400 |
Why?
| Hypertriglyceridemia | 1 | 2010 | 25 | 0.400 |
Why?
| Homeless Persons | 2 | 2020 | 23 | 0.390 |
Why?
| Medical Errors | 2 | 2021 | 31 | 0.380 |
Why?
| Workplace | 2 | 2021 | 26 | 0.380 |
Why?
| Diet, Mediterranean | 1 | 2010 | 57 | 0.380 |
Why?
| Health Status | 3 | 2021 | 249 | 0.380 |
Why?
| Nurse Clinicians | 1 | 2009 | 28 | 0.370 |
Why?
| Medical Order Entry Systems | 1 | 2008 | 4 | 0.370 |
Why?
| Primary Health Care | 2 | 2020 | 106 | 0.350 |
Why?
| Self Care | 1 | 2009 | 104 | 0.350 |
Why?
| Mental Health | 2 | 2021 | 119 | 0.340 |
Why?
| Women's Health Services | 2 | 2018 | 12 | 0.340 |
Why?
| Referral and Consultation | 1 | 2008 | 99 | 0.340 |
Why?
| Attitude of Health Personnel | 1 | 2009 | 181 | 0.330 |
Why?
| Patient Education as Topic | 4 | 2011 | 192 | 0.330 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2011 | 224 | 0.320 |
Why?
| Blood Pressure | 8 | 2015 | 260 | 0.320 |
Why?
| Heart Diseases | 1 | 2008 | 102 | 0.320 |
Why?
| Health Services Accessibility | 3 | 2020 | 113 | 0.310 |
Why?
| Patient Acceptance of Health Care | 2 | 2020 | 85 | 0.290 |
Why?
| Patient Care Team | 2 | 2019 | 153 | 0.280 |
Why?
| Atherosclerosis | 2 | 2018 | 57 | 0.280 |
Why?
| Male | 21 | 2020 | 17583 | 0.280 |
Why?
| Cross-Sectional Studies | 6 | 2021 | 986 | 0.280 |
Why?
| American Heart Association | 5 | 2021 | 39 | 0.270 |
Why?
| Obesity | 4 | 2016 | 338 | 0.270 |
Why?
| Women's Health | 3 | 2018 | 228 | 0.260 |
Why?
| Self Efficacy | 2 | 2021 | 65 | 0.240 |
Why?
| Treatment Outcome | 10 | 2021 | 3910 | 0.240 |
Why?
| Lipoprotein(a) | 2 | 2016 | 10 | 0.230 |
Why?
| Military Medicine | 1 | 2021 | 15 | 0.220 |
Why?
| Social Support | 2 | 2021 | 224 | 0.210 |
Why?
| Chicago | 5 | 2016 | 955 | 0.210 |
Why?
| Palliative Care | 2 | 2020 | 146 | 0.210 |
Why?
| Qualitative Research | 2 | 2019 | 127 | 0.210 |
Why?
| Exercise Therapy | 2 | 2008 | 116 | 0.200 |
Why?
| Endothelium | 1 | 2020 | 15 | 0.200 |
Why?
| Muscle, Skeletal | 2 | 2017 | 385 | 0.200 |
Why?
| Quality of Life | 3 | 2020 | 663 | 0.200 |
Why?
| Preventive Medicine | 1 | 2019 | 13 | 0.190 |
Why?
| Heart Transplantation | 1 | 2020 | 50 | 0.190 |
Why?
| Residence Characteristics | 3 | 2016 | 226 | 0.190 |
Why?
| Insurance Coverage | 1 | 2019 | 18 | 0.190 |
Why?
| Vascular Diseases | 1 | 2020 | 59 | 0.190 |
Why?
| Counseling | 2 | 2010 | 63 | 0.190 |
Why?
| Hyperlipoproteinemia Type II | 1 | 2019 | 5 | 0.190 |
Why?
| Physician-Patient Relations | 1 | 2019 | 47 | 0.190 |
Why?
| Physical Endurance | 3 | 1997 | 13 | 0.180 |
Why?
| Consensus | 4 | 2021 | 106 | 0.180 |
Why?
| Nurse's Role | 2 | 2011 | 145 | 0.180 |
Why?
| Posture | 1 | 1999 | 92 | 0.180 |
Why?
| Prognosis | 4 | 2018 | 1028 | 0.180 |
Why?
| Decision Support Techniques | 1 | 2018 | 55 | 0.180 |
Why?
| Marital Status | 1 | 2018 | 15 | 0.180 |
Why?
| Cholesterol, HDL | 2 | 2012 | 34 | 0.180 |
Why?
| Delivery of Health Care, Integrated | 1 | 2018 | 30 | 0.170 |
Why?
| Ambulatory Care Facilities | 1 | 2018 | 42 | 0.170 |
Why?
| Occupational Health | 1 | 2018 | 27 | 0.170 |
Why?
| Blogging | 1 | 2017 | 2 | 0.170 |
Why?
| Information Storage and Retrieval | 1 | 2017 | 5 | 0.170 |
Why?
| Heart Failure | 2 | 2020 | 232 | 0.170 |
Why?
| Antihypertensive Agents | 1 | 2018 | 91 | 0.170 |
Why?
| Program Evaluation | 2 | 2015 | 153 | 0.170 |
Why?
| Adolescent | 5 | 2015 | 2667 | 0.170 |
Why?
| Muscular Diseases | 1 | 2017 | 23 | 0.170 |
Why?
| Sex Characteristics | 1 | 2018 | 128 | 0.160 |
Why?
| Self Concept | 1 | 1997 | 54 | 0.160 |
Why?
| Quality Improvement | 1 | 2018 | 173 | 0.160 |
Why?
| Prevalence | 4 | 2016 | 544 | 0.150 |
Why?
| Health Expenditures | 1 | 2015 | 20 | 0.150 |
Why?
| Patient Dropouts | 1 | 2015 | 31 | 0.150 |
Why?
| Evidence-Based Nursing | 1 | 2016 | 27 | 0.150 |
Why?
| Smoking | 2 | 2007 | 202 | 0.150 |
Why?
| Age Factors | 3 | 2018 | 943 | 0.150 |
Why?
| Cognition | 2 | 2020 | 1206 | 0.140 |
Why?
| Patient-Centered Care | 1 | 2015 | 66 | 0.140 |
Why?
| Catecholamines | 1 | 1994 | 17 | 0.140 |
Why?
| Physical Fitness | 2 | 1994 | 57 | 0.140 |
Why?
| Cardiac Output | 1 | 1994 | 24 | 0.140 |
Why?
| Cardiomegaly | 1 | 1994 | 20 | 0.130 |
Why?
| Nutritional Sciences | 1 | 2014 | 13 | 0.130 |
Why?
| Adaptation, Physiological | 1 | 1994 | 63 | 0.130 |
Why?
| Socioeconomic Factors | 1 | 2015 | 362 | 0.130 |
Why?
| Spouses | 1 | 2014 | 29 | 0.130 |
Why?
| Pets | 1 | 2013 | 1 | 0.130 |
Why?
| Geriatric Nursing | 1 | 2013 | 26 | 0.130 |
Why?
| Morbidity | 2 | 2011 | 71 | 0.130 |
Why?
| Needs Assessment | 1 | 2013 | 50 | 0.120 |
Why?
| Liver Function Tests | 1 | 2012 | 33 | 0.120 |
Why?
| Creatine Kinase | 1 | 2012 | 36 | 0.120 |
Why?
| Health Personnel | 1 | 2014 | 108 | 0.120 |
Why?
| Advanced Practice Nursing | 1 | 2013 | 47 | 0.120 |
Why?
| Child | 3 | 2015 | 1572 | 0.110 |
Why?
| Warfarin | 1 | 2012 | 60 | 0.110 |
Why?
| Education, Nursing, Graduate | 1 | 2013 | 91 | 0.110 |
Why?
| Exercise Test | 4 | 2005 | 123 | 0.110 |
Why?
| Specialties, Nursing | 1 | 2011 | 11 | 0.110 |
Why?
| Interdisciplinary Communication | 1 | 2011 | 31 | 0.110 |
Why?
| Cardiovascular Physiological Phenomena | 1 | 1991 | 5 | 0.110 |
Why?
| Predictive Value of Tests | 2 | 2018 | 637 | 0.110 |
Why?
| Anticoagulants | 1 | 2012 | 151 | 0.110 |
Why?
| Protective Factors | 2 | 2021 | 19 | 0.100 |
Why?
| Homocysteine | 2 | 2007 | 11 | 0.100 |
Why?
| Aged, 80 and over | 6 | 2020 | 5234 | 0.100 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2020 | 26 | 0.100 |
Why?
| Oxygen Consumption | 4 | 1997 | 65 | 0.100 |
Why?
| Sex Factors | 3 | 2018 | 542 | 0.100 |
Why?
| Early Ambulation | 1 | 1989 | 20 | 0.100 |
Why?
| Behavioral Risk Factor Surveillance System | 1 | 2009 | 3 | 0.100 |
Why?
| Quality of Health Care | 4 | 2014 | 141 | 0.100 |
Why?
| Nursing Methodology Research | 1 | 2009 | 39 | 0.100 |
Why?
| Atrial Fibrillation | 1 | 2012 | 197 | 0.090 |
Why?
| Societies, Nursing | 1 | 2009 | 25 | 0.090 |
Why?
| Feasibility Studies | 2 | 2020 | 281 | 0.090 |
Why?
| Medication Therapy Management | 2 | 2018 | 6 | 0.090 |
Why?
| Feeding Behavior | 1 | 2010 | 122 | 0.090 |
Why?
| Child, Preschool | 1 | 2011 | 786 | 0.090 |
Why?
| Health Services Needs and Demand | 1 | 2008 | 71 | 0.090 |
Why?
| Exercise Tolerance | 1 | 2008 | 29 | 0.090 |
Why?
| Survival Rate | 1 | 2010 | 465 | 0.090 |
Why?
| Quality Indicators, Health Care | 1 | 2008 | 43 | 0.090 |
Why?
| Time Factors | 3 | 2021 | 1902 | 0.090 |
Why?
| Mass Screening | 2 | 2018 | 199 | 0.080 |
Why?
| Drug Monitoring | 2 | 2021 | 29 | 0.080 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2020 | 375 | 0.080 |
Why?
| Muscle Strength | 1 | 2008 | 134 | 0.080 |
Why?
| Inflammation | 1 | 2010 | 360 | 0.080 |
Why?
| Clofibric Acid | 1 | 2006 | 3 | 0.080 |
Why?
| Alcoholism | 1 | 2007 | 90 | 0.080 |
Why?
| C-Reactive Protein | 1 | 2006 | 134 | 0.080 |
Why?
| Activities of Daily Living | 1 | 1989 | 495 | 0.070 |
Why?
| Self Report | 2 | 2021 | 225 | 0.070 |
Why?
| Anxiety | 2 | 2018 | 162 | 0.070 |
Why?
| Body Composition | 2 | 2016 | 81 | 0.070 |
Why?
| Body Weight | 2 | 2016 | 167 | 0.070 |
Why?
| Lipids | 1 | 2005 | 56 | 0.070 |
Why?
| Comorbidity | 1 | 2006 | 562 | 0.070 |
Why?
| Young Adult | 3 | 2018 | 2277 | 0.070 |
Why?
| Cost-Benefit Analysis | 2 | 2015 | 153 | 0.060 |
Why?
| Incidence | 1 | 2006 | 829 | 0.060 |
Why?
| Nurse Practitioners | 2 | 2016 | 119 | 0.060 |
Why?
| Stress, Psychological | 2 | 2018 | 281 | 0.060 |
Why?
| Depression | 2 | 2018 | 516 | 0.060 |
Why?
| Risk | 1 | 2003 | 228 | 0.060 |
Why?
| Lipoproteins | 1 | 2001 | 13 | 0.060 |
Why?
| United States Department of Defense | 1 | 2021 | 2 | 0.060 |
Why?
| United States Department of Veterans Affairs | 1 | 2021 | 10 | 0.060 |
Why?
| Postmenopause | 1 | 2001 | 66 | 0.060 |
Why?
| Organizational Culture | 1 | 2021 | 22 | 0.050 |
Why?
| Triglycerides | 1 | 2001 | 50 | 0.050 |
Why?
| Clinical Competence | 2 | 2014 | 274 | 0.050 |
Why?
| Insulin Resistance | 1 | 2001 | 71 | 0.050 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2020 | 70 | 0.050 |
Why?
| Follow-Up Studies | 3 | 2017 | 2028 | 0.050 |
Why?
| Listeria monocytogenes | 1 | 1999 | 5 | 0.050 |
Why?
| Listeriosis | 1 | 1999 | 6 | 0.050 |
Why?
| Coronary Circulation | 1 | 2020 | 49 | 0.050 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 1999 | 9 | 0.050 |
Why?
| Leg | 1 | 1999 | 51 | 0.050 |
Why?
| Diabetes Mellitus | 1 | 2020 | 150 | 0.040 |
Why?
| Analysis of Variance | 2 | 1997 | 364 | 0.040 |
Why?
| Regression Analysis | 2 | 1997 | 319 | 0.040 |
Why?
| Critical Care | 1 | 2021 | 234 | 0.040 |
Why?
| Walking | 1 | 2020 | 249 | 0.040 |
Why?
| Membrane Proteins | 1 | 1999 | 230 | 0.040 |
Why?
| Health Status Disparities | 1 | 2018 | 70 | 0.040 |
Why?
| Memory Disorders | 1 | 2019 | 181 | 0.040 |
Why?
| Telephone | 1 | 2017 | 33 | 0.040 |
Why?
| Healthcare Disparities | 1 | 2018 | 82 | 0.040 |
Why?
| Perception | 1 | 2018 | 92 | 0.040 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2020 | 193 | 0.040 |
Why?
| Heart Rate | 2 | 1995 | 161 | 0.040 |
Why?
| Social Class | 1 | 2016 | 71 | 0.040 |
Why?
| Georgia | 1 | 2016 | 16 | 0.040 |
Why?
| Models, Organizational | 1 | 2016 | 27 | 0.040 |
Why?
| Hemiplegia | 1 | 1995 | 7 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1994 | 43 | 0.030 |
Why?
| Up-Regulation | 1 | 2016 | 220 | 0.030 |
Why?
| Stress, Physiological | 1 | 1994 | 26 | 0.030 |
Why?
| Dental Hygienists | 1 | 2014 | 1 | 0.030 |
Why?
| Pharmacists | 1 | 2014 | 16 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 1994 | 96 | 0.030 |
Why?
| Models, Educational | 1 | 2014 | 41 | 0.030 |
Why?
| Pregnancy | 1 | 2015 | 457 | 0.030 |
Why?
| Education, Medical | 1 | 2014 | 45 | 0.030 |
Why?
| Social Networking | 1 | 2013 | 10 | 0.030 |
Why?
| Efficiency | 1 | 2013 | 21 | 0.030 |
Why?
| Cerebrovascular Disorders | 1 | 1995 | 123 | 0.030 |
Why?
| Models, Theoretical | 1 | 2014 | 112 | 0.030 |
Why?
| Cats | 1 | 2013 | 79 | 0.030 |
Why?
| Propranolol | 1 | 1992 | 13 | 0.030 |
Why?
| Hemodynamics | 1 | 2013 | 103 | 0.030 |
Why?
| Rest | 1 | 1992 | 33 | 0.030 |
Why?
| Dogs | 1 | 2013 | 283 | 0.030 |
Why?
| Interviews as Topic | 1 | 2013 | 152 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 1994 | 467 | 0.030 |
Why?
| Administration, Oral | 1 | 2012 | 164 | 0.030 |
Why?
| Survival Analysis | 1 | 2013 | 379 | 0.030 |
Why?
| Physicians | 1 | 2014 | 120 | 0.030 |
Why?
| Data Collection | 1 | 2012 | 120 | 0.030 |
Why?
| Curriculum | 1 | 2013 | 158 | 0.030 |
Why?
| Foundations | 1 | 2011 | 4 | 0.030 |
Why?
| Chronic Disease | 1 | 1994 | 544 | 0.030 |
Why?
| Statistics as Topic | 1 | 2011 | 124 | 0.030 |
Why?
| Signal Transduction | 1 | 1994 | 588 | 0.030 |
Why?
| Energy Metabolism | 1 | 1991 | 82 | 0.030 |
Why?
| Reperfusion | 1 | 1989 | 12 | 0.020 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 230 | 0.020 |
Why?
| Monitoring, Physiologic | 1 | 1989 | 100 | 0.020 |
Why?
| Stroke | 1 | 2012 | 367 | 0.020 |
Why?
| Arm | 1 | 2008 | 78 | 0.020 |
Why?
| Blood Glucose | 1 | 2007 | 137 | 0.020 |
Why?
| Retrospective Studies | 1 | 2016 | 3591 | 0.020 |
Why?
| Rotator Cuff | 1 | 2008 | 252 | 0.020 |
Why?
| Aging | 1 | 1994 | 1614 | 0.020 |
Why?
| Animals | 1 | 2013 | 5312 | 0.020 |
Why?
| Leucine | 1 | 1999 | 18 | 0.010 |
Why?
| Sequence Alignment | 1 | 1999 | 29 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1999 | 254 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1999 | 315 | 0.010 |
Why?
| Bacterial Proteins | 1 | 1999 | 90 | 0.010 |
Why?
| Body Mass Index | 1 | 2001 | 458 | 0.010 |
Why?
| Sensation | 1 | 1995 | 18 | 0.010 |
Why?
| Blood Pressure Determination | 1 | 1992 | 22 | 0.010 |
Why?
| Reproducibility of Results | 1 | 1992 | 886 | 0.010 |
Why?
|
|
Braun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|